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Summary
Objectives: To generate and validate a murine model of joint surface repair following acute mechanical injury.
Methods: Full thickness defects were generated in the patellar groove of C57BL/6 and DBA/1 mice by microsurgery. Control knees were either
sham-operated or non-operated. Outcome was evaluated by histological scoring systems. Apoptosis and proliferation were studied using TU-
NEL and Phospho-Histone H3 staining, respectively. Type II collagen neo-deposition and degradation were evaluated by immunostaining
using antibodies to the CPII telopeptide and C1,2C (Col2-3/4Cshort), respectively. Aggrecanases and matrix metalloproteinases (MMPs)
activity were assessed by immunostaining for TEGE373 and VDIPEN neo-epitopes.
Results: Young 8-week-old DBA/1 mice displayed consistent and superior healing of the articular cartilage defect. Age-matched C57BL/6
mice repaired poorly and developed features of osteoarthritis (OA). Compared to C57BL/6, DBA/1 mice displayed a progressive decline of
chondrocyte apoptosis, cell proliferation within the repair tissue, persistent type II collagen neo-deposition, less type II collagen degradation,
less aggrecanases and more MMP-induced aggrecan degradation. Eight-month-old DBA/1 mice failed to repair, but, in contrast to age-
matched C57BL/6 mice, developed no signs of OA.
Conclusion: We have generated and validated a murine model of cartilage regeneration in which the outcome of joint surface injury is strain
and age dependent. This model will allow, for the ﬁrst time, the dissection of different pathways involved in joint surface regeneration in adult
mammals using the powerful technology of mouse genetics.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd.
Key words: Cartilage repair, Joint surface defects, Cartilage regeneration, Animal models, osteoarthritis, Cartilage injury, apoptosis, Metallo-
proteinases, regenerative medicine.
Open access under the Elsevier OA license.Introduction
Joint surface defects (JSD) are observed in over 60% of all
arthroscopic procedures1,2 often are symptomatic and dis-
abling2,3, associated with cartilage loss, progression towards
osteoarthritis (OA), and predict prosthetic joint replace-
ment4,5. Cartilage breakdown is the invalidating outcome of
most rheumatic conditions causing pain and disability for mil-
lions of people world-wide. Therefore, joint surface restora-
tion is a major priority in modern medicine. The natural
history of JSD, however, varies from spontaneous healing
to OA development6e8, depending on patient-related factors
including age, body weight and co morbidity, as well as
factors related to the defect including site, size, depth and se-
verity of the injury7e10. Structural and functional restoration
of joint surface integrity after chondral or osteochondral le-
sions has been documented in high number of individuals,aThese authors share senior authorship.
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695in an age-dependent fashion7,11,12. Additionally, spontane-
ous repair has been reported in large animal models of full
thickness joint surface injury such as rabbits, dogs and
horses13e15. These data, along with the fact that the joint en-
vironment is rich in progenitor/stem cells13,16,17, suggest the
presence of intrinsic repair mechanisms capable of recruiting
resident stem cells to the site of damage and controlling their
fate decisions and differentiation18.
Surgical therapeutic approaches such as microfracture,
mosaicplasty and autologous chondrocyte implantation
(ACI) are currently used to treat symptomatic localized
chronic full thickness chondral lesions3,19,20. However,
none of these procedures is optimal due to issues related
to costs, invasiveness, durability of repair tissue, in vitro
cell manipulations, outcome variability and difﬁcult up scal-
ing21,22. A regeneration process that could be initiated and
supported using bioactive compounds delivered at the site
of injury to trigger/enhance the intrinsic repair capacity of
adult joints would be a desirable alternative approach to
overcome these problems21. Unfortunately, the understand-
ing of the molecular and cellular mechanisms underpinning
the regulation of joint surface healing and, consequently,
the identiﬁcation of potential therapeutic targets has been
hindered by the unavailability of well characterized small
animal models suitable to test the function of individual
Table I
The number of mice killed per time point
Strain Age No. of animals Time point
DBA/1 8 Weeks 15 8 Weeks
C57Bl/6 8 Weeks 15 8 Weeks
DBA/1 8 Months 15 8 Weeks
C57Bl/6 8 Months 15 8 Weeks
DBA/1 8 Weeks 5 1 Day
C57Bl/6 8 Weeks 5 1 Day
DBA/1 8 Weeks 5 1 Week
C57Bl/6 8 Weeks 5 1 Week
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rently available models exist in large animals13e15 that are
not amenable for genetic manipulation. In this study, we
have generated and validated a murine model in which
the repair outcome of a well controlled, consistent and re-
producible joint surface injury is dependent on the strain
and the age of the mice. This work describes a novel joint
surface regeneration model in adult animals, in a species
that is widely validated as a preclinical model and that is
amenable to genetic manipulation, thus allowing functional
molecular studies in the process of joint surface healing.DBA/1 8 Weeks 5 4 Weeks
C57Bl/6 8 Weeks 5 4 Weeks
Total 90Materials and methodsOPERATIVE PROCEDUREAll procedures were approved by the Local Ethics committee and the UK
Home Ofﬁce.
Male mice were anesthetized using ketamine (40 mg/kg) and xylazine
(5 mg/kg). Medial para-patellar arthrotomy was performed under a dissection
microscope (Leica), by inserting microsurgical scalpel medially and proxi-
mally to the insertion of the patellar tendon on the tibia and extending it prox-
imally until the attachment of the quadriceps muscle. The medial margin of
the quadriceps was separated from the muscles of the medial compartment.
The joint was extended and the patella was dislocated laterally. The joint was
then fully ﬂexed to expose the patellar groove. A longitudinal full thickness
injury was made in the patellar groove using a custom made device in which
a glass bead was placed approximately 200 mm to the tip of a 26 G needle
(Fig. 1A). The tip of the needle was placed anteriorly to the intercondylar
notch and gently moved along the entire length of the patellar groove
(Fig. 1A). The patellar dislocation was then reduced. The joint capsule and
the skin were sutured in separate layers. The contra-lateral knee was either
left non-operated or subjected to arthrotomy and patellar dislocation without
cartilage injury (sham-operated controls). The number of mice in each age
group, at each time point is shown in Table I.TISSUE PROCESSING AND HISTOLOGYKnee joints were ﬁxed, decalciﬁed, parafﬁn embedded and serially sec-
tioned at 5 mm interval. Only sections between planes A and C (Fig. 1B)Fig. 1. Consistency and reproducibility of surgically induced full thickness
eration of a full thickness defect in the patellar groove. The patellar groov
placed with its tip just anteriorly to the intercondylar notch (lower end of do
patellar groove (dotted line). (B) Schematic representation of a mouse kne
the sections comprised between A and C intersects the growth plate in 4 p
outside this interval (section on the right). (CeE), Histomorphometric comp
(C) and the percentage of defect depth to cartilage thickness (D) in C57B
expressed as mean standard error of the mean (S.E.M.). P¼ patella; PT
[For interpretation of color in this ﬁgure legend, the rwere used for analysis. Plane A is 100 mm proximal to the intercondylar
notch, plane B is 100 mm proximal to plane A and plane C is 100 mm proximal
to plane B. Within this interval, the sections intercept the growth plate in four
points and this was used as landmark for section level (Fig. 1B). Sections A,
B, and C were used for histomorphometry and scoring. The other sections
comprised in the AeC interval were used for immunohistochemical staining.
Hematoxylin & eosin and safranin-O fast green staining (for highly sulfated,
negatively charged glycosaminoglycans) were performed according to stan-
dard protocols. Slides were analyzed with an Olympus BX61 microscope
and Cell-P software (Olympus UK Ltd, UK).HISTOMORPHOMETRY AND SCORINGHistomorphometry and scoring were performed at the levels indicated in
Fig. 1B and the values were averaged for each knee. Cartilage thickness,
depth, cross-sectional width (CSW) and cross-sectional area (CSA) of the
JSD were measured 1 day after joint surface injury. The defect-depth/carti-
lage thickness ratio and the coefﬁcient of variation were represented as per-
centage. Joint surface repair was scored as previously described23,24 and
OA was assessed using Modiﬁed Mankin score25,26. Scoring was per-
formed independently by two observers blinded to the group assignment.
All the data are expressed as the mean standard error of the mean
(S.E.M.).JSD. (A) Cadaveric preparation (right knee joint) to show the gen-
e is exposed by lateral dislocation of the patella (P). The devise is
tted line) and dragged proximally in the centre of the entire length of
e joint (articular cartilage in yellow and the growth plate in blue). All
oints (sections AeC on the left). This landmark is absent in sections
arison of cartilage thickness, depth and CSW of the defect (B), CSA
L/6 and DBA/1 mice 1 day after surgery (n¼ 5). All the values are
¼ patellar tendon; Q¼ quadriceps muscle and T¼ tibial tuberosity.
eader is referred to web version of the article.]
697Osteoarthritis and Cartilage Vol. 17, No. 6APOPTOSIS DETECTION (TUNEL ANALYSIS)Detection of apoptotic cells was performed coupling the terminal deoxnu-
cleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay and
the cytological appearance of the cells. The TUNEL assay was performed
according to the manufacturer’s protocol (R&D systems, UK).IMMUNOFLUORESCENCE STAININGSections were deparafﬁnized; pepsin digested as previously describe-
d27and blocked in serum free protein blocking solution (DAKO, UK). After
overnight incubation with either rabbit antihuman/mouse Phospho-Histone
H3 1:50 (PHH3; cell signaling technology, USA) or rabbit antihuman/mouse
CP II antibodies 1:800 (kindly provided by Dr Lindsay King from IBEX, Can-
ada), sections were incubated with cy3 conjugated goat antirabbit antibody
1:600 (Jackson ImmunoResearch Laboratories, USA). Slides were mounted
in Mowiol (Calbiochem, Merck Biosciences Ltd, Nottingham, UK) containing
4,6-diamindino-2-phenylindole (DAPI; ICN, Stretton Scientiﬁc Ltd, UK).IMMUNOLOCALIZATION OF COLLAGENASE, AGGRECANASES
AND MMPs INDUCED EPITOPESSections were deparafﬁnized and digested with chondroitinase ABC
(Sigma, UK) in 0.1 M TriseHCl, pH 8.0 for 1 h at 37C. Endogenous perox-
idase activity was quenched by incubating the sections with 3% H2O2. Sec-
tions were blocked and incubated overnight with the primary antibody:
antiC1,2C (Col2-3/4Cshort) 1:800 (IBEX, Canada), anti-TEGE373 or anti-
VDIPEN 1:10 (kindly provided by Professor Bruce Caterson and Dr Debbie
Tudor, Cardiff University). Sections were incubated with EnVisionþDual
Link system-HRP (DakoCytomation, UK). DAB Substrate Chromogen Sys-
tem (DakoCytomation, UK) was used as peroxidase substrate. Sections
were counterstained with hematoxylin and mounted with DPX (BDH, UK).
The speciﬁcity of the stainings with positive and negative controls is shown
in Supplementary Figure 1.STATISTICAL ANALYSISThe mean histological scores were compared using the ManneWhitney U
test for unpaired non-parametric data. Student’s unpaired t-test was used for
the other comparisons between the two strains. Differences were considered
statistically signiﬁcant when P was <0.05.ResultsREPRODUCIBILITY AND CONSISTENCY OF JOINT SURFACE
INJURYTo assess the consistency of the experimental JSD at dif-
ferent levels within the same mouse, in different mice, and
in mice of different strains, we compared histomorphometric
measurements of cartilage thickness and injury size
(Table II) at three different planes within the patellar groove
of each mouse (Fig. 1B). The thickness of the articular car-
tilage within the analyzed interval was comparable in
C57BL/6 and DBA/1 mice (Fig. 1C). Depth, CSW, and
CSA of the defects were very consistent and highly repro-
ducible within the same joint, and across different mice
with no statistically signiﬁcant difference between the two
strains analyzed (Fig. 1C, D). Importantly, in all operated
animals, the defects were consistently full thickness within
the analyzed interval (Fig. 1E).Table I
The mean and the standard error of the mean (S
Depth CSW




DBA/1 70.36 3.84 mm, 141.31 29.37 mm,
CV¼ 5.3% CV¼ 22.3%
CV¼ coefﬁcient of variation.STRUCTURAL OUTCOME OF ACUTE JOINT SURFACE INJURYOne day after injury, there was no difference between the
two adult strains as evaluated by histomorphometry
(Fig. 1CeE) and histology (Fig. 2A). At 1-week time point,
undifferentiated spindle shaped cells partially ﬁlled the
defects in DBA/1 mice. By 4 weeks, the tissue ﬁlling the de-
fects in DBA/1 mice consisted of chondrocytes surrounded
by safranin-O stained matrix. However, this repair tissue
lacked the typical architecture of normal articular cartilage
as the superﬁcial, intermediate, and deep layers were not
morphologically distinguishable and the bone front had
not reached the level of the osteochondral boundary as in
the surrounding cartilage. After 8 weeks, there was a com-
plete ﬁlling of the defects with well organized safranin-O
positive hyaline-like cartilage (Fig. 2A). Polarized light
microscopy showed ﬁbers crossing the boundary between
repair tissue and original cartilage, thereby indicating
integration; however, superﬁcial irregularities and ﬁbrillar
discontinuity were sometimes observed (not shown). In
contrast, the lesions induced in C57BL/6 mice healed
poorly as undifferentiated ﬁbroblast-like cells invaded only
the bottom of the defects 4 weeks after injury. At later
time points, defects were partially ﬁlled with thin cancellous
bone covered by a superﬁcial layer of ﬁbrous tissue
(Fig. 2A). The repair scores in DBA/1 mice were statistically
signiﬁcantly lower (better repair) than C57BL/6 at 4 and 8
weeks after injury (Fig. 2C).
In addition to the different repair outcome, only C57BL/6
mice displayed progressive features of OA in the articular
cartilage of the patellar groove as early as 1 week after in-
jury. Initially, these features included small hypo- or a-cellu-
lar areas, surface ﬁbrillation and faint safranin-O staining
adjacent to the experimental defect. Subsequent, progres-
sion included cluster formation, clefts, focal lesions and
loss of safranin-O metachromasia. Later on, these features
extended to cartilage areas far from the experimental injury
(Fig. 2A, B and D).
At all time points analyzed, no histological differences in
the articular cartilage of the patellar groove were detected
within the interval analyzed between the sham operated
and non-operated controls from both strains as evaluated
by H&E and safranin-O staining (Fig. 2A).CELL DEATH AND PROLIFERATIONApoptosis has been described as a pathogenic mecha-
nism of cartilage breakdown in OA28,29. In the injured joints,
apoptotic cells were identiﬁed in the proximity of the injury
and at the edge of articular cartilage at day 1 in young
mice of both strains (Fig. 3A, B). In consecutive H&E
stained section, pyknotic nuclei were present in the same
areas (Fig. 3C). In subsequent time points, chondrocyte ap-
optosis in DBA/1 mice progressively decreased and nearly
disappeared at 4 and 8 weeks time points (Fig. 3A, B),
whereas in C57BL/6 mice, after an initial ﬂexion, apoptosisI
.E.M.) of histomorphometric measurements





6988.2 1541.56 mm2, 104.64% 2.58
CV¼ 23.3%
Fig. 2. Outcome of acute mechanical cartilage injury. (A) H&E (left) and safranin-O (right) staining of sections from sham operated and injured
joints of 8 weeks old C57BL/6 and DBA/1 mice at the indicated time points. (B) Higher magniﬁcation of H&E stained sections from injured
C57BL/6 showing areas away from the experimental lesion with various degrees of OA. (CeD), repair score (C) and modiﬁed Mankin score
(D) at 4 (n¼ 5) and 8 (n¼ 15) weeks time points. Low score in C indicated better repair and high score in D indicated more severe OA. All the
values are expressed as mean standard error of the mean (S.E.M.). *P< 0.05. [For interpretation of color in this ﬁgure legend, the reader is
referred to web version of the article.]
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with statistically signiﬁcant difference to DBA/1 mice
(Fig. 3AeC). In the articular cartilage of the sham and
non-operated knee joints, we did not detect any TUNEL-
positive cells at all the time points analyzed (Fig. 3A).
Although chondrocyte proliferation has been reported to
take place following injury28, we only detected scattered
proliferating cells within the repair tissue at 1 and 4 weeks
following injury in DBA/1 mice but not in the articular carti-
lage adjacent to the injury in either of the two strains, as
assessed by PHH3 staining (Fig. 3D).TYPE II COLLAGEN NEO-SYNTHESIS AND DEGRADATIONTo study type II collagen neo-synthesis, we immuno-
stained the C-terminal telopeptide cleaved from type II pro-
collagen molecules using antiCPII antibody30. In the control
and sham-operated joints, the collagen C-telopeptide was
detected in the mineralized deep layer of the articular carti-
lage (Fig. 4A). Following injury, pericellular CPII staining
was observed in the superﬁcial and intermediate zones. In
these areas, collagen type II neo-synthesis peaked 1
week after injury in both strains, but subsequently declined
Fig. 3. Cell death and proliferation. (A), TUNEL assay in sham-operated and injured joints of young mice at 1 day and 8 weeks after injury. Red
arrows indicate apoptotic nuclei (green). Nuclei are counterstained with DAPI (blue). The asterisk indicates the injury site. (B), Numbers of ap-
optotic cells at different time points comparing both strains. The values are expressed asmean and standard deviation of three different operated
mice using three sections from each joint. *P< 0.05. (C), Higher magniﬁcation of the areas squared in (A) at 1 day and 8 weeks time points,
respectively, and H&E staining of a consecutive section. Pyknotic nuclei are indicated with black arrowheads. (D), Phospho-Histone H3
immunoﬂuorescence, and H&E staining of a consecutive section at 1 and 4 weeks time points. White arrows indicate proliferating cells (red).
Nuclei are counterstained with DAPI (blue). The numbers of proliferating cells counted in three mice using three sections from each joint are
shown as mean and standard deviation. [For interpretation of color in this ﬁgure legend, the reader is referred to web version of the article.]
699Osteoarthritis and Cartilage Vol. 17, No. 6in C57BL/6, while persisted in DBA/1 mice for at least 8
weeks and became conﬁned to the newly formed cartilage
(Fig. 4A, B). The number of CPII-positive chondrocytes
was statistically signiﬁcantly higher in DBA/1 mice at 4
and 8 weeks time points (Fig. 4B).
We then compared type II collagen degradation in both
strains utilizing anti C1, 2C (Col2-3/4Cshort) antibody that rec-
ognizes the carboxy-terminal end of the collagenase-gener-
ated fragment of type II collagen. Intact uninjured articular
cartilage from sham and non-operated joints showed weak
pericellular C1, 2C staining in both C57BL/6 and DBA/1
young mice (Fig. 4C). As early as 1 week and for at least 8
weeks following injury, immunostaining increased in both
strains. The repair tissue in DBA/1 mice, however, displayed
a weaker staining than the adjacent cartilage (Fig. 4C).AGGRECAN CLEAVAGE BY AGGRECANASES AND MMPs
ACTIVITYProteoglycan turnover is central to cartilage homeostasis.
To compare proteoglycan aggrecan breakdown in youngmice from both strains in vivo following injury, we performed
immunostaining for aggrecan neo-epitopes generated by ag-
grecanases and matrix metalloproteinases MMPs (TEGE373
and VDIPEN, respectively). In sham and non-operated con-
trol joints, both strains exhibited similar staining patterns
(Fig. 5A, B). As early as 1 day after injury and thereafter,
C57BL/6 mice displayed increased TEGE373 staining and
low levels of VDIPEN. An opposite expression pattern was
detected in DBA/1 mice with weak TEGE373 and intense
VDIPEN staining (Fig. 5A, B). These ﬁndings indicate that
aggrecan is prevalently degraded by aggrecanases in the
C57BL/6 and by MMPs in DBA/1 strain.THE REPAIR OUTCOME IN AGED MICEAge is a factor inﬂuencing the outcome of JSD in hu-
mans7,9 and animal models31 with older individuals being
less likely to have spontaneous healing. To investigate
the effect of ageing, we challenged 8-month-old C57BL/6
and DBA/1 mice in this model. Aged animals from both
strains reproducibly failed to repair the defect. However,
Fig. 4. Collagen synthesis and degradation. (A), Immunoﬂuorescence staining for type II collagen C-telopeptide (A) in 8-week-old C57BL/6
(left) and DBA/1 (right). Type II collagen C-telopeptide is shown in red and nuclei are counterstained with DAPI (blue). (B), The number of
C-telopeptide positive chondrocytes within the superﬁcial and intermediate layer. The values from three different mice from each strains at
the indicated time point are expressed as mean and standard deviation. *P< 0.05. (C), Immunostaining of C1, 2C neoepitope in C57BL/6
(left) and DBA/1 (right). Negligible staining is seen in the repair tissue in DBA/1 mice. [For interpretation of color in this ﬁgure legend, the reader
is referred to web version of the article.]
Fig. 5. Aggrecan degradation. Immunostaining of aggrecanase (TEGE373, A) and MMPs (VDIPEN, B) generated neoepitope (brown) in the
articular cartilage of 8-week-old C57BL/6 and DBA/1. Nuclei are counterstained with hematoxylin (blue). [For interpretation of color in this
ﬁgure legend, the reader is referred to web version of the article.]
700 N. M. Eltawil et al.: A novel in vivo murine model of cartilage regeneration
701Osteoarthritis and Cartilage Vol. 17, No. 6whereas C57BL/6 mice developed severe diffuse knee OA,
DBA/1 mice did not show any sign of OA at all time points
analyzed (Fig. 6).
Discussion
Traumatic cartilage lesions represent a common symp-
tomatic and disabling problem1,2 that often requires surgical
intervention to relieve pain and to prevent possible evolution
towards secondary OA3,19,20. The absence of relevant pre-
clinical animal models of joint surface regeneration suitable
for molecular studies and genetic manipulation has repre-
sented a bottleneck for the development of novel therapeu-
tics to enhance/support joint surface repair. In this study, we
have developed and characterized a mouse model of acute
full thickness JSD with a strain and age dependent repair
outcome. Adult DBA/1 mice reproducibly healed experi-
mental joint surface lesions, whereas age-matched
C57BL/6 healed poorly and instead developed features of
secondary OA. Aged mice failed to repair, but, in contrast
to age-matched C57BL/6 mice, DBA/1 developed no signs
of secondary OA. The strain-dependent different outcome
in young animals was associated with different regulation
of apoptosis, proliferation and matrix remodeling.
Since the repair of JSD depends largely on their size and
depth7,9,10, the reproducibility of the injury in our model was
an important concern. We therefore measured the size of the
defects focusing the analysis on the interval between planes
A and C (Fig. 1B) because, within this region, the articular
cartilage is of uniform thickness and it is well exposed during
surgery after patellar dislocation. Importantly, the intersec-
tion of the growth plate within these planes provided a useful
anatomical landmark. We achieved a high reproducibility
and consistency of the injury by combining a well controlled
sampling technique within a selected anatomical area and
the design of a simple and reliable device to induce the in-
jury. Importantly, all the defects were full thickness in all
the animals and slightly deeper than 100% of the cartilageFig. 6. Structural outcome in aged mice. (A), H&E (left) and safranin-O (ri
and DBA/1 mice 8 weeks after surgery. The lower panel shows higher m
Mankin score at 8 weeks time points (n¼ 15). All the values arethickness. Such consistency was largely ensured by the re-
sistance offered by the subchondral bone, the resilience of
the 26 G needle used to make the device, and the presence
of the glass bead which by adapting to the concavity of the
patellar groove, allowed the tip of the needle to run reproduc-
ibly in the centre of the patellar groove.
C57BL/6 mice develop spontaneous OA with ageing32
and they are more susceptible than DBA/1 to OA induced
by destabilization of the medial meniscus (DMM)33. How-
ever, spontaneous OA appears in C57BL/6 mice only after
their ﬁrst year of age, and no signs of OA were present in
control or sham-operated joints in our study. It is therefore
unlikely that pre-existing OA or joint instability inadvertently
induced during surgery were the causes for repair failure.
On the other hand, the generation of a JSD in C57BL/6
mice precipitated the appearance of secondary OA features
as early as 1 week after injury. At 4 weeks, when the OA
features in C57BL/6 mice had advanced, there was also
a clear difference in repair outcome compared to DBA/1.
It is possible that the rapid development of secondary OA
may have conditioned repair failure. Our experimental setup
does not discriminate whether the failure of repair and the
development of OA are causally related, or if they represent
distinct processes resulting from an inferior joint homeo-
static mechanism in C57BL/6 than in DBA/1 mice. How-
ever, the observation that aged DBA/1 mice did not repair
and did not develop OA either, under our experimental con-
ditions and at the time points examined, demonstrates that
repair failure alone may not be sufﬁcient for the develop-
ment of secondary OA and suggests that the two processes
may be, at least in part, uncoupled.
On the other hand, DBA/1 mice are responsive to inﬂam-
matory arthritis models such as type II collagen-induced ar-
thritis whereas C57BL/6 mice are resistant34. A modest
inﬁltrate was present in the synovial membrane of the two
strains during the ﬁrst week following surgery (data not
shown); however, it is possible that a different inﬂammatory
response may play a role in repair outcomes.ght) staining of sections from injured joints of 8-month-old C57BL/6
agniﬁcation of the areas squared in the upper panel. (B), Modiﬁed
expressed as mean standard error of the mean (S.E.M.).
702 N. M. Eltawil et al.: A novel in vivo murine model of cartilage regenerationNon-differentiated spindle-like cells ﬁlled the lesions in
DBA/1 mice at 1 week. In C57BL/6, morphologically similar
cells appeared in the defects after 4 weeks when chondro-
genesis had already occurred in DBA/1 mice. This delay in
populating the wound could be due to differences reported
in proliferation rate, cell surface epitopes and differentiation
potential between bone marrow mesenchymal stem cells
(MSCs) isolated from C57BL/6 and DBA/1 with higher chon-
drogenic potential of DBA/1 MSCs35. Additional potential
mechanism could be a delayed activation/migration of mes-
enchymal progenitors in response to cartilage signals re-
leased by injured cartilage27. We recently showed that
genes encoding morphogens, chemokines and other
signaling molecules are activated in human adult articular
cartilage after mechanical injury36. Failure of either the car-
tilage to deploy such response to injury or the mesenchymal
progenitor/stem cells to respond to such signaling mole-
cules may contribute to the delay of C57BL/6 mesenchymal
cells in ﬁlling the defect.
Chondrocyte apoptosis progressively resolved in DBA/1
mice and persisted inC57BL/6 for at least 8weeks. Chondro-
cyte death followingmechanical injury and its potential role in
the pathogenesis of OA have been described in several stud-
ies28,29,37,38. However, apoptotic cells may play a positive
role in the repair responses by releasing chemo-attractants
for stem/progenitor cells such as high mobility group box 1
(HMGB1)39. Therefore, it is possible that controlled chondro-
cyte apoptosis, in the initial phases of repair, may play a sim-
ilar function after cartilage injury; however, it could be
detrimental if not tightly regulated and inappropriately pro-
longed.Our experimental setup does not allow discriminating
whether the prolonged apoptosis in C57BL/6 is determining
or a consequence of repair failure.
Proliferation in the cartilage surrounding the injury site
has been reported following mechanical trauma28,40. We
did not detect chondrocyte proliferation in the articular car-
tilage surrounding the injury. However, proliferating cells
were identiﬁed within the repair tissue in DBA/1 mice at 1
and 4 weeks post-surgery. This discrepancy with previous
literature could be due to differences in the experimental
conditions, the time points analyzed and the detection sys-
tems used. We examined the phosphorylation of histone H3
which is tightly correlated with the chromosome condensa-
tion phase during mitosis, thereby representing a snapshot
of cells in M phase of cell cycle41. Conversely, incorporation
of labeled nucleosides marks all the cells undergoing DNA
duplication during the labeling period. Furthermore, cell pro-
liferation in adult tissues occurs at a very low rate, and may
take place in a short time-span after repair, thus our time
points might have missed proliferation within the cartilage
surrounding the injury. Surrounding tissues such as bone
marrow and synovium have been proposed to contribute
cells to the reparative process in different in vivo injury
models13,42. However, the origin of the cells populating
the defects and ultimately forming the repair cartilage in
DBA/1 mice remains to be clariﬁed.
Our study shows a prompt activation of matrix remodeling
after injury within the repair tissue in DBA/1 mice and in the
remaining cartilage in both strains. Matrix remodeling has
been described in response to injury28,43, during OA44,45
and in human repair cartilage tissue obtained from ACI46.
Interestingly, in this study, DBA/1 mice maintained a high
level of collagen type II neo-synthesis and a low collagen
catabolic activity for 8 weeks after injury. However,
C57BL/6 mice exhibited a reverse pattern with progressive
decrease in the number of CP II positive cells and intense
Col2-3/4Cshort staining. Aggrecan degradation wasprevalently driven by aggrecanases in C5BL/6 mice and
by MMPs in DBA/1 mice.
Recently, ADAMTS-5 has been identiﬁed as the main
aggrecanase in mouse cartilage and its ablation protected
the mice fromOA induced by DMM47. Similarly, mutants har-
boring a genetic allele of the aggrecan gene that blocks ag-
grecanases mediated cleavage were also protected when
challenged in DMMmodel, but, interestingly, mice harboring
an aggrecan mutant allele that is resistant to MMP-mediated
cleavage developed more severe OA than their wild-type lit-
termates48. Moreover, MMP9-deﬁcient mice were more sus-
ceptible to OA than their wild-type littermates in the same
model33. Taken together, these data and our results conﬁrm
the critical role of aggrecanases in cartilage destruction and
suggest that a controlled level of MMP-mediated aggreca-
nolysis may be needed for cartilage homeostasis, and possi-
bly repair, as MMPs proteolysis can facilitate cell migration,
regulate tissue architecture, release and activate ECM
bound growth factors and signaling molecules49. A caveat,
in the interpretation of our data, is that aggrecan cleaved
by aggrecanases may be internalized50 and thereby no lon-
ger available for MMPs cleavage even in the presence of ac-
tive MMPs. This may explain why, in C57BL/6, although
several MMPs can cleave collagen and aggrecan, we only
detected cleaved type II collagen. Another explanation for
this discrepancy is that different MMPs may be responsible
for aggrecan and collagen type II cleavage. Understanding
these events would be crucial for the identiﬁcation of the cor-
rect window of therapeutic intervention with inhibitors of ag-
grecanases and MMPs that are being developed and
tested in preclinical and clinical studies51.
The JSD repair encompasses highly coordinated biologi-
cal events that require a ﬁne tuning of diverse processes in-
cluding cellular apoptosis, proliferation and tissue patterning
regulated in a temporalespatial manner. The molecular
mechanisms regulating this process are poorly understood
and their study has been hampered by the lack of suitable
models. We anticipate that this newmodel of joint surface in-
jury and repair, combined with mouse genetics, will be instru-
mental to elucidate the molecular control of these events,
thereby enabling the development of new therapeutic agents
to improve joint surface healing. It must stressed that this
model is not a model of primary OA, but rather a model of
joint surface injury and repair. However, the occurrence of
post-traumatic OA features in C57BL/6 mice suggest it could
be used to study the mechanism by which repair inﬂuences
progression of post-traumatic secondary OA.
We and others27,36,52,53 have demonstrated that the in-
jured articular cartilage deploys a robust response to injury
with activation of genes encoding signaling molecules and
morphogens. This could be the effect of a putative repair re-
sponse, or an adaptive response to damage, or could even
play a role in post-traumatic secondary OA development.
This model will allow addressing the functionality and hier-
archy of molecules in the response to injury and subse-
quently represents a preclinical in vivo model to develop
novel molecular therapeutics to support joint surface heal-
ing in cell-free in situ tissue engineering approaches.
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